We theorized that FIR may inhibit platelet-endothelium interactions by altering the proportion of ULvWFs in HD patients through ADAMTS13, providing another perspective on the protective effect of FIR on AVFs. The gene discussed is ADAMTS13; the disease is Huntington disease.